05 11月 2019 by admin in UncategorizedComments Syros to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019
05 11月 2019 by admin in UncategorizedComments resTORbio Reports Third Quarter 2019 Financial Results and Corporate Update
04 11月 2019 by admin in UncategorizedComments NextCure to Host and Webcast Event at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
25 10月 2019 by admin in UncategorizedComments New Biotechnology publication validates Crescendo Biologics’ platform as it moves towards the clinic
17 10月 2019 by admin in UncategorizedComments Syros Announces Update on Selective CDK7 Inhibitor Portfolio
07 10月 2019 by admin in UncategorizedComments Tempest Therapeutics Names Biopharmaceutical Executive Stephen Brady as President and Chief Operating Office
